Results 201 to 210 of about 1,443,667 (357)

Anti-Idiotype × Anti-CD44 Bispecific Antibodies Inhibit Invasion of Lymphoid Organs by B Cell Lymphoma [PDF]

, 2004
Esther Avin, Joseph Haimovich, Nurit Hollander   +2 more
openalex   +1 more source

130. Targeting of Adenovirus Vectors to Mesothelin Via a Bispecific Antibody Reveals Enhanced Gene Transfer to Human Pancreatic Cancer Cells [PDF]

, 2004
MA van Geer, No Value Pastan, VW van Beusechem, Hidde J. Haisma, PJ Bosma, DJ Gouma, J. Wesseling   +6 more
openalex   +1 more source

Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non‐Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group

British Journal of Haematology, EarlyView.
Summary Developing new therapeutic regimens for relapsed/refractory (R/R) B non‐Hodgkin lymphoma (NHL) patients remains a significant unmet clinical need. Our objective was to evaluate atezolizumab (ATE), obinutuzumab (OBI) and venetoclax (VEN) combination in patients with R/R NHL who had received at least one prior anti‐CD20‐containing ...
Charles Herbaux, Emmanuel Bachy, Reda Bouabdallah, Stéphanie Guidez, Olivier Casasnovas, Pierre Feugier, Gandhi Damaj, Hervé Tilly, Loïc Ysebaert, Steven Le Gouill, Nadine Morineau, Emmanuel Gyan, Rémy Gressin, Roch Houot, Morgane Cheminant, Franck Morschhauser, Catherine Thieblemont, Corinne Haioun, Emmanuelle Nicolas‐Virelizier, Luc‐Matthieu Fornecker, Nicolas Daguindau, Guillaume Cartron   +21 more
wiley   +1 more source

The dark sides of the GPCR tree ‐ research progress on understudied GPCRs

British Journal of Pharmacology, EarlyView.
Abstract A large portion of the human GPCRome is still in the dark and understudied, consisting even of entire subfamilies of GPCRs such as odorant receptors, class A and C orphans, adhesion GPCRs, Frizzleds and taste receptors. However, it is undeniable that these GPCRs bring an untapped therapeutic potential that should be explored further.
Magdalena M. Scharf, Laura J. Humphrys, Sandra Berndt, Antonella Di Pizio, Juliane Lehmann, Ines Liebscher, Alessandro Nicoli, Masha Y. Niv, Lior Peri, Hannes Schihada, Gunnar Schulte   +10 more
wiley   +1 more source

Recombinant bispecific antibodies for cancer therapy [PDF]

, 2005
Roland E. Kontermann
openalex   +1 more source

Composite Lymphoma: A Rare Case of Vomiting

United European Gastroenterology Journal, EarlyView.
Changqin Liu, Dongyan Han, Xiaomin Sun
wiley   +1 more source

Opportunities to Modulate Tumor Ecosystem Toward Successful Glioblastoma Immunotherapy

Cancer Science, EarlyView.
There remain outstanding gaps between the negative results from clinical trials and the actual potential of the immune system for glioblastoma. To bridge this crucial gap, we collaborated with Dr. Mariko Takahashi, an expert in immunobiology and drug development, and Dr. James J.
Mariko Takahashi, Darina Mukhamejanova, Himani Jasewicz, Nandini Acharya, James J. Moon, Toshiro Hara   +5 more
wiley   +1 more source

Recombinant approaches to IgG-like bispecific antibodies [PDF]

, 2005
Jonathan S. Marvin, Zhenping Zhu
openalex   +1 more source

Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity

Cancer Immunology and Immunotherapy, 2020
Yan Wang, Haiqing Ni, Shuaixiang Zhou, K. He, Yarong Gao, Weiwei Wu, Min Wu, Zhihai Wu, X. Qiu, Ying Zhou, Bingliang Chen, D. Pan, Chenrong Huang, Mingzhu Li, Yicong Bian, Min Yang, L. Miao, Junjian Liu   +17 more
semanticscholar   +1 more source

Bispecific Antibodies and Gene Therapy

, 2011
Gene therapy is the transfer of therapeutic genes, via gene transfer vectors, into patients for therapeutic purposes. Different gene therapy strategies are being pursued, including long-term gene correction of monogenetic diseases, eradication of tumor cells in cancer patients, or genetic vaccination for infectious diseases.
openaire   +2 more sources